On March 14, 2022, Raymond Pratt notified Rockwell Medical, Inc. of his decision to resign as the Company's Chief Development Officer, effective as of March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | 0.00% | -2.23% | -7.41% |
30/05 | Rockwell Medical, Inc. Promotes Tim Chole to Chief Commercial Officer | CI |
14/05 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.41% | 5.34Cr | |
+42.83% | 75TCr | |
+34.11% | 61TCr | |
-5.70% | 36TCr | |
+18.06% | 33TCr | |
+4.63% | 29TCr | |
+17.75% | 25TCr | |
+10.82% | 21TCr | |
-3.03% | 21TCr | |
+2.43% | 17TCr |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Raymond Pratt Resigns from Rockwell Medical, Inc. as Chief Development Officer, Effective March 25, 2022